COMBINATION OF A GREMLIN-1 ANTAGONIST WITH AN INHIBITOR OF RAS-RAF-MEK-ERK SIGNALLING

Abstract: the present invention relates to an anti-grem1 antagonist for use in a method for the treatment or prevention of a cancer in combination with an inhibitor of ras-raf-mek-erk signalling.

Inventor(s): GARETH CHARLES GLYNDWR DAVIES, PAUL JONES, BRAM JEROEN VAN DE SANDE, JENNIFER PATRICIA MORTON

CPC Classification: A61K31/4365 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250228826